Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction
×
Capecitabine
×
Clear all
Filters
3
NCT01630083
2025-06-15
FAST
Astellas Pharma Inc
Phase 2
Completed
252 enrolled